Tag: gadolinium

guerbet

Guerbet announces US Food and Drug Administration approval of Elucirem

Guerbet announced that the US Food and Drug Administration (FDA), after priority review, has approved Elucirem (Gadopiclenol), a new macrocyclic gadolinium-based contrast agent (GBCA)...

Study finds no evidence that gadolinium causes neurologic harm

There is no evidence that accumulation in the brain of the element gadolinium speeds cognitive decline, according to a new study presented at the...